Literature DB >> 10701892

Mortality in epilepsy.

T Tomson1.   

Abstract

Both community-based studies and reports from more selected epilepsy populations consistently reveal persons with epilepsy to have a mortality rate two to three times that of the general population. This increased rate is most pronounced in patients with remote symptomatic epilepsy, although many studies also report a significant excess mortality also among those with idiopathic epilepsy. The highest standardized mortality ratios (SMR) are seen in young age groups, mainly due to the low expected mortality in children, and during the first 5-10 years after diagnosis. Many of these observations suggest that the higher mortality is partly related to the underlying disorder causing epilepsy rather than a direct consequence of the seizures. For example, mortality in cerebrovascular diseases is increased, with SMRs ranging from 1.8 to 5.3 in the various studies. Deaths due to neoplasms, and in particular brain tumors, is also increased among patients with epilepsy. Accidents, status epilepticus, and sudden unexpected death (SUD) are more directly seizure-related causes of death. The incidence of such deaths vary considerably depending on the population being studied. While rare among patients with new-onset epilepsy, seizure-related deaths may account for up to 40% of all deaths in patients with chronic epilepsy. SUD is probably the most frequent seizure-related cause of death among young adults with epilepsy, with an SMR more than 20 compared with the general population. Seizure-induced autonomic cardiorespiratory effects have been suggested, but the mechanisms behind SUD are far from fully understood. It appears, however, that the risk of SUD is closely related to seizure frequency, being 40 times higher in patients who continue to have seizures than in those who are seizure-free.

Entities:  

Mesh:

Year:  2000        PMID: 10701892     DOI: 10.1007/s004150050004

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 2.  The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson
Journal:  Epilepsia       Date:  2016-11-26       Impact factor: 5.864

3.  Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study.

Authors:  Olli Nevalainen; Jani Raitanen; Hanna Ansakorpi; Miia Artama; Jouko Isojärvi; Anssi Auvinen
Journal:  Eur J Epidemiol       Date:  2013-09-26       Impact factor: 8.082

Review 4.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 5.  Recent advances in epilepsy.

Authors:  Stjepana Kovac; Matthew C Walker
Journal:  J Neurol       Date:  2014-03-04       Impact factor: 4.849

6.  Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy.

Authors:  Mark W Lowerison; Colin B Josephson; Nathalie Jetté; Tolulope T Sajobi; Scott Patten; Tyler Williamson; Rob Deardon; Herman W Barkema; Samuel Wiebe
Journal:  JAMA Neurol       Date:  2019-11-01       Impact factor: 18.302

7.  Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.

Authors:  Lisen Arnheim-Dahlström; Jonas Hällgren; Caroline E Weibull; Pär Sparén
Journal:  BMJ       Date:  2012-12-18

8.  Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures.

Authors:  James W Mitchell; Stefano Seri; Andrea E Cavanna
Journal:  J Cent Nerv Syst Dis       Date:  2012-06-19

Review 9.  Managing drug-resistant epilepsy: challenges and solutions.

Authors:  Linda Dalic; Mark J Cook
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-12       Impact factor: 2.570

10.  A review of the epidemiology of temporal lobe epilepsy.

Authors:  Jose F Téllez-Zenteno; Lizbeth Hernández-Ronquillo
Journal:  Epilepsy Res Treat       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.